Cynthia Arbeeny

Company: Mitotherapeutix

Job title: Chief Scientific Officer

Seminars:

Pioneering Mito-1041: A Novel siRNA Approach to Modulate Mitochondrial Function for Tissue Selectivity & Specificity 11:40 am

Transforming siRNA as a state-of-the-art therapeutic for treating mitochondrial impairment through gene specificity and organ selectivity Highlighting various methods of siRNA delivery to address distinguishing features of organs for restoration of mitochondrial function Creating a roadmap to develop MITO-1041 and related compounds as a novel, safe and effective mitochondrial therapy for treating metabolic-associated liver disease…Read more

day: CONFERENCE DAY TWO